From: Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
Univariate
Multivariate
p - value
95% C.I.
Hazard ratio
Age
0.044
%UD90(%)
0.004
1.037
0.007
1.010-1.064
%UD30 (%)
0.011